INTENSITY THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
INTENSITY THERAPEUTICS, INC. (INTS) reported Basic Shares Outstanding (Weighted Average) of 2.71 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- INTENSITY THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 2.71M shares, a 258.62% increase year-over-year.
- INTENSITY THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 2.53M shares, a 317.50% increase year-over-year.
- INTENSITY THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was -71.96M shares.
- INTENSITY THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 43.04M shares, a 211.80% increase year-over-year.
- INTENSITY THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 1.36M shares, a 143.83% increase from fiscal 2024.
- INTENSITY THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 556.28K shares, a 93.54% decline from fiscal 2023.
- INTENSITY THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 8.62M shares, a 152.67% increase from fiscal 2022.
- INTENSITY THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 3.41M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.71M shares 10-Q · filed 2026-08-11 | 2.62M shares 10-Q · filed 2026-08-11 | -22.24M shares derived: average of 3 quarters · filed 2026-08-11 | -5.92M shares derived: average of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | 2.53M shares 10-Q · filed 2026-05-07 | -34.72M shares derived: average of 2 quarters · filed 2026-05-07 | -8.80M shares derived: average of 3 quarters · filed 2026-05-07 | -6.41M shares derived: average of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | -71.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -14.46M shares derived: average of 2 quarters · filed 2026-03-27 | -9.39M shares derived: average of 3 quarters · filed 2026-08-11 | 1.36M shares 10-K · filed 2026-03-27 | |||
| 2025-09-30 | 43.04M shares 10-Q · filed 2025-11-06 | 21.90M shares derived: average of 2 quarters · filed 2026-08-11 | 25.80M shares 10-Q · filed 2025-11-06 | 1.35M shares derived: average of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | 754.73K shares 10-Q · filed 2026-08-11 | 18.87M shares 10-Q · filed 2025-08-07 | 681.24K shares 10-Q · filed 2026-08-11 | 17.03M shares 10-Q · filed 2025-08-07 | -12.55M shares derived: average of 3 quarters · filed 2026-08-11 | -5.96M shares derived: average of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | 606.93K shares 10-Q · filed 2026-05-07 | 15.17M shares 10-Q · filed 2025-05-13 | -19.20M shares derived: average of 2 quarters · filed 2026-05-07 | -8.20M shares derived: average of 3 quarters · filed 2026-05-07 | -2.72M shares derived: average of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -39.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -12.60M shares derived: average of 2 quarters · filed 2026-03-27 | -3.83M shares derived: average of 3 quarters · filed 2026-03-27 | 556.28K shares 10-K · filed 2026-03-27 | 13.91M shares 10-K · filed 2025-03-13 | ||
| 2024-09-30 | 13.80M shares 10-Q · filed 2025-11-06 | 13.76M shares derived: average of 2 quarters · filed 2025-11-06 | 13.74M shares 10-Q · filed 2025-11-06 | 13.75M shares derived: average of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | 13.71M shares 10-Q · filed 2025-08-07 | 13.71M shares 10-Q · filed 2025-08-07 | 13.73M shares derived: average of 3 quarters · filed 2025-08-07 | 13.71M shares derived: average of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | 13.71M shares 10-Q · filed 2025-05-13 | 13.74M shares derived: average of 2 quarters · filed 2025-05-13 | 13.71M shares derived: average of 3 quarters · filed 2025-05-13 | 11.16M shares derived: average of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | 13.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 13.71M shares derived: average of 2 quarters · filed 2025-03-13 | 10.31M shares derived: average of 3 quarters · filed 2025-03-13 | 8.62M shares 10-K · filed 2025-03-13 | |||
| 2023-09-30 | 13.66M shares 10-Q · filed 2024-11-13 | 8.59M shares derived: average of 2 quarters · filed 2024-11-13 | 6.90M shares 10-Q · filed 2024-11-13 | 6.00M shares derived: average of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | 3.52M shares 10-Q · filed 2024-08-08 | 3.46M shares 10-Q · filed 2024-08-08 | 3.45M shares derived: average of 3 quarters · filed 2024-08-08 | 3.44M shares derived: average of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | 3.41M shares 10-Q · filed 2024-05-09 | 3.41M shares derived: average of 2 quarters · filed 2024-05-09 | 3.41M shares derived: average of 3 quarters · filed 2024-05-09 | 3.41M shares derived: average of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | 3.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 3.41M shares derived: average of 2 quarters · filed 2024-03-14 | 3.41M shares derived: average of 3 quarters · filed 2024-03-14 | 3.41M shares 10-K · filed 2024-03-14 | |||
| 2022-09-30 | 3.41M shares 10-Q · filed 2023-11-13 | 3.41M shares derived: average of 2 quarters · filed 2023-11-13 | 3.41M shares 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 3.41M shares 10-Q · filed 2023-08-14 | 3.41M shares 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |